中药有效组分配伍防治肝病的研究现状与前景  

Prevention and treatment of liver diseases by compatibility of effective traditional Chinese medicine components:review of research and prospect

作　　者：孟胜喜[1] 胡义扬[1,2,3] 

机构地区：[1]上海中医药大学附属曙光医院肝病研究所,上海201203 [2]教育部肝肾疾病病证重点研究室,上海201203 [3]上海市中医临床重点实验室,上海201203

出　　处：《临床肝胆病杂志》2014年第4期295-298,共4页Journal of Clinical Hepatology

基　　金：国家科技重大专项(2012ZX09103-201-048);国家自然科学基金(81173404);国家中医药管理局中医肝胆病重点学科

摘　　要：中药有效成分复方秉承中药复方配伍理念和优势,其物质基础相对明确,是中医药现代化研究的重要途径和方法。简述了中药组分/成分复方的研究意义、研究思路,回顾了中药组分复方防治肝病研究现状,并从基于临床中药复方的组分复方探索和针对已知的中药有效组分或成分进行组合研究等两方面详细阐释了中药组分/复方防治肝病的研究策略,指出中药有效组分配伍为创新药物的研究提供了方法和技术体系,是一种继承并发扬中医药理论的创新研究模式,是中医药现代研究的重要途径之一。The compound of active ingredients of traditional Chinese medicine （TCM）, whose material base is relatively clear, adheres to the concept and advantages of formula compatibility of TCM. Thus, it is an important approach to modern TCM research. The significance of research on compound of TCM components/ingredients, as well as the research ideas, is sketched out, and the current research on compound of TCM components for the prevention and treatment of liver diseases is reviewed. The research strategies for TCM composition/compound for the prevention and treatment of liver diseases are elucidated from the following two aspects： exploring the compound of TCM components based on clinical TCM compound and studying the composition aiming at the effective components or ingredients of TCM that have been known ; it is pointed out that the compatibility of effective TCM components, which provides the method and technology system for innovative drug research, is an innovative research model for inheriting and developing the TCM theory and is one of the important approaches to modem TCM research.

关 键 词：肝疾病 中草药 复方合剂 综述 

分 类 号：R259[医药卫生—中西医结合]